Please login to the form below
Wave adds senior programme executive
Mehwish Abdeali joins the medical education agency from Circle Health
Wave Healthcare Communications has appointed Mehwish Abdeali to its team as senior programme executive.
She joins the Amersham, UK-based medical education agency from Circle Health's CircleReading Hospital, where she was primary care manager with additional responsibility for business development.
James Seed, co-owner and director of Wave, said: “Mehwish's appointment strengthens our capacity and expertise to deliver our range of medical education programmes.”
Abdeali brings with her extensive experience in organising medical educational events for healthcare professionals in a range of therapeutic areas.
Abdeali said: “I am looking forward to using my experience to work with the Wave team as we enter this busy congress season."
COVID-19 Updates and Daily News
Featured jobs
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
-
Planner
-
Salary TBC
- Client Services Director, Patient Engagement & Solutions, Lo...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
-
Senior Account Manager
-
Salary TBC
- Group Account Director, Patient Engagement & Solutions, Lond...
-
Highly competitive salary
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Novartis highlights potential of its radioligand therapy in prostate cancer at ASCO
- Merck signs $1.2bn supply deal with US government for Molnupiravir
- AZ, Pfizer/BioNTech COVID-19 vaccines 'highly effective' against Indian variant
- Piloting a route to the biosimilars opportunities in Europe
- FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
- Biogen, Sage’s depression therapeutic zuranolone hits primary endpoint in phase 3
- The power of communication: Engaging diverse groups in healthcare
- US trial data shows Novavax’s COVID-19 vaccine is 90% effective
- AZ’s long-acting COVID-19 antibody fails to meet primary endpoint in prevention trial
- J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
- Novartis’ iptacopan scores positive results in rare blood disorder PNH
- First NHS patient treated with Novartis’ SMA gene therapy Zolgensma
- FDA approves Biogen’s aducanumab for Alzheimer’s disease in ‘landmark’ decision
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Novo Nordisk says Victoza outperforms SGLT2 inhibitors
- FDA advisory committee overwhelmingly votes no on Biogen's aducanumab
- Pfizer CEO says oral COVID-19 pill could be ready by the end of the year
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- The power of communication: Engaging diverse groups in healthcare
- Humans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to a group, a cohort or an imagined section of society - especially...
- Building the hospital of the future
- Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
- Why people join a clinical trial
- To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
